(S)-1-(4-(4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)-2-(pyrrolidin-2-yl)ethanone

ID: ALA4555271

PubChem CID: 155556073

Max Phase: Preclinical

Molecular Formula: C25H31F2N9O2

Molecular Weight: 527.58

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(C[C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1

Standard InChI:  InChI=1S/C25H31F2N9O2/c26-21(27)22-29-18-5-1-2-6-19(18)36(22)25-31-23(30-24(32-25)35-12-14-38-15-13-35)34-10-8-33(9-11-34)20(37)16-17-4-3-7-28-17/h1-2,5-6,17,21,28H,3-4,7-16H2/t17-/m0/s1

Standard InChI Key:  GOJHJBFUANKGFP-KRWDZBQOSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
    3.3735  -19.6745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3723  -20.5019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0871  -20.9147    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8036  -20.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8007  -19.6709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0853  -19.2618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0829  -18.4368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7941  -18.0251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7936  -17.2038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0797  -16.7896    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3647  -17.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3635  -18.0306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6576  -20.9138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5186  -20.9128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9027  -20.5791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3502  -21.1918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5157  -21.7379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2267  -22.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9429  -21.7391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9436  -20.9132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2280  -20.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5692  -21.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7622  -21.9043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5064  -22.6859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0564  -23.2996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8657  -23.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1177  -22.3449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7308  -19.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3437  -19.2200    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9461  -19.5176    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.6564  -22.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3718  -21.7422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0853  -22.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1724  -22.9743    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9789  -23.1475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3931  -22.4340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8423  -21.8198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6546  -22.9782    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  2 13  1  0
  4 14  1  0
 13 15  1  0
 15 16  2  0
 16 23  1  0
 22 13  1  0
 14 17  1  0
 14 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 15 28  1  0
 28 29  1  0
 28 30  1  0
 19 31  1  0
 31 32  1  0
 33 32  1  6
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 33  1  0
 31 38  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4555271

    ---

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CD Tclin PI3-kinase p110-delta subunit (6699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.58Molecular Weight (Monoisotopic): 527.2569AlogP: 1.78#Rotatable Bonds: 6
Polar Surface Area: 104.54Molecular Species: BASEHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 10.62CX LogP: 2.88CX LogD: -0.06
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.51Np Likeness Score: -1.11

References

1. Miller MS, Mountford SJ, Pinson JA, Zheng Z, Künzli M, Patel V, Hogg SJ, Shortt J, Jennings IG, Thompson PE..  (2016)  Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ.,  26  (19): [PMID:27561716] [10.1016/j.bmcl.2016.08.028]

Source